BackLiquidia Overview
Liquidia Corp

Liquidia Target Price

Where could LQDA trade next? Consensus target price: $88.

Get informed when a big investor buys or sells

+ Follow

Share Price

$68.66

Average Target Price

$87.5327.5% upside

15 analysts in the last 4 months

High: $130 | Low: $28

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Raymond James$10654.4% upsideOpen
2026-08-13Wells Fargo$10857.3% upsideOpen
2026-07-24Stephens$13089.3% upsideOpen
2026-07-24H.C. Wainwright$3647.6% downsideOpen
2026-07-24Piper Sandler$12987.9% upsideOpen
2026-07-24RBC Capital$13089.3% upsideOpen
2026-07-23H.C. Wainwright$13089.3% upsideOpen
2026-06-22BTIG$10958.8% upsideOpen
2026-06-05H.C. Wainwright$759.2% upsideOpen
2026-06-05H.C. Wainwright$2859.2% downsideOpen
2026-06-05Oppenheimer$759.2% upsideOpen
2026-06-04Raymond James$681% downsideOpen
2026-05-12H.C. WainwrightAndrew Fein$672.4% downsideOpen
2026-05-12Wells Fargo$629.7% downsideOpen
2026-05-11JefferiesAmy Li$6012.6% downsideOpen
2026-01-13JefferiesAmy Li$5519.9% downsideOpen
2025-11-04H.C. Wainwright$5027.2% downsideOpen
2025-11-04Raymond JamesRyan Deschner$4731.5% downsideOpen
2025-11-03Jefferies$4534.5% downsideOpen
2025-05-19OppenheimerAndreas Argyrides$1381.1% downsideOpen
2025-05-05ScotiabankGreg Harrison$3647.6% downsideOpen
2025-03-20ScotiabankGreg Harrison$3450.5% downsideOpen
2025-01-09NeedhamSerge Belanger$1972.3% downsideOpen
2024-08-20Bank of America SecuritiesJason Gerberry$2366.5% downsideOpen
2024-08-19JefferiesKambiz Yazdi$1775.2% downsideOpen
2024-08-19Raymond JamesStrong Buy$2760.7% downsideOpen
2024-05-14JefferiesKambiz Yazdi$2366.5% downsideOpen
2022-09-02Needham$1676.7% downsideOpen
2022-09-01WedbushLiana Moussatos$395.6% downsideOpen
2022-07-20BTIG$1775.2% downsideOpen

Liquidia (LQDA) FAQ

As of the most recent data, LQDA shows a target price of $88. Scroll down for historical charts and peer comparison views.

If Liquidia moved to the average analyst target of $88, shares would be roughly 27.5% higher than $68.66. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Liquidia's earnings trajectory.

Besides this target price page, Stockcircle has Liquidia's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $88) with ownership activity and broader fundamentals.

Liquidia's target price is $88; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.